Search

Your search keyword '"cardiomyopathy"' showing total 64,063 results

Search Constraints

Start Over You searched for: Descriptor "cardiomyopathy" Remove constraint Descriptor: "cardiomyopathy"
64,063 results on '"cardiomyopathy"'

Search Results

1. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).

2. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOS.

3. In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin.

4. Cardiomyopathy in Patients With Acute Ischemic Stroke and Methamphetamine Use: Relevance for Cardioembolic Stroke and Outcome.

5. Myosin folding boosts solubility in cardiac muscle sarcomeres.

6. Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.

7. Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

8. Balloon atrial septostomy versus left atrial cannulation for left heart decompression in children with dilated cardiomyopathy and myocarditis on extracorporeal membrane oxygenation: An ELSO registry analysis.

9. Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters.

10. Molecular autopsy in Chinese sudden cardiac death in the young.

11. Known pathogenic gene variants and new candidates detected in sudden unexpected infant death using whole genome sequencing.

12. Exploration of Clozapine-Induced Cardiomyopathy and Its Mechanism.

13. PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study.

14. Obesity cardiomyopathy could contribute to sudden cardiac death: a Japanese epidemiological morphological study.

15. Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation.

16. Metoprolol use is associated with improved outcomes in patients with sepsis-induced cardiomyopathy: an analysis of the MIMIC-IV database.

17. The Role of BAG3 Protein Interactions in Cardiomyopathies.

18. Metabolomics: Implication in cardiovascular research and diseases.

19. History and Perspective of LAMP-2 Deficiency (Danon Disease).

20. Comparación del mapa T1, T2 y VEC por RMC en pacientes con miocardiopatía inflamatoria post-COVID-19 vs. daño miocárdico de etiología autoinmune.

21. Mitral Valve Repair in Pediatric Patients with Dilated Cardiomyopathy and Mitral Insufficiency: Single-Center Experience and Results.

22. NT-proBNP Reflects Left Ventricular Hypertrophy Rather than Left Ventricular Dilatation or Systolic Dysfunction in Patients with Fabry Disease.

23. Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach.

24. Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications.

25. Cardiac and skeletal muscle manifestations in the G608G mouse model of Hutchinson‐Gilford progeria syndrome.

26. Disturbed Atrial Conduction in Patients with Duchenne Muscular Dystrophy.

28. Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum.

29. RBM20和MURC双基因杂合变异对心肌细胞结构和 生物学特性的影响.

30. Baseline Characteristics and Clinical Insights from the ARTEMIS Registry: A Comprehensive Study of Peripartum Cardiomyopathy in Türkiye.

31. Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers.

32. A pilot study of the proarrhythmic effects of pimobendan injection in clinically healthy cats.

33. VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients.

34. Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan.

35. Acacetin is a Promising Drug Candidate for Cardiovascular Diseases.

36. Predictors of cardiac disease in duchenne muscular dystrophy: a systematic review and evidence grading.

37. LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1.

38. The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failure.

39. Baseline Predictors of Adverse Outcomes for Transthyretin Amyloidosis Cardiomyopathy Patients Treated and Untreated with Tafamidis: A Canadian Referral Center Experience.

40. Aggravation of Cardiovascular and Respiratory Decline in Advanced Duchenne Muscular Dystrophy Complicated by Dilated Cardiomyopathy -- Case Study and Review of Literature.

41. Assessing the effectiveness and safety of Patisiran and Vutrisiran in ATTRv amyloidosis with polyneuropathy: a systematic review.

42. Whole-exome sequencing to identify causative variants in juvenile sudden cardiac death.

43. Identification of macrophage driver genes in fibrosis caused by different heart diseases based on omics integration.

44. Exploring novel MYH7 gene variants using in silico analyses in Korean patients with cardiomyopathy.

45. Genetic testing in early-onset atrial fibrillation.

46. Systemic sclerosis sine scleroderma is more aggressive in children than in adults.

47. PRKAG2 Variant, Motor Neuron Disease, and Parkinsonism: Fortuitous Association or a Potentially Underestimated Pathophysiological Mechanism?

48. 2D speckle tracking in echocardiography in hypertrophic cardiomyopathy and its relation to hypertrophy and late gadolinium enhancement extent.

49. Hypocalcemic cardiomyopathy with heart failure: A rare Case report.

50. Aerobic Exercise Attenuates Doxorubicin-Induced Cardiomyopathy by Suppressing NLRP3 Inflammasome Activation in a Rat Model.

Catalog

Books, media, physical & digital resources